Journal
DISEASE MODELS & MECHANISMS
Volume 6, Issue 3, Pages 608-621Publisher
COMPANY OF BIOLOGISTS LTD
DOI: 10.1242/dmm.010900
Keywords
-
Categories
Funding
- US Friedreich's Ataxia Research Alliance (USA)
- Association Francaise pour l'Ataxie de Friedreich
- Association Francaise contre les Myopathies
- Ministere de l'economie, de l'industrie et de l'emploi
- European Community under the European Research Council [206634/ISCATAXIA]
- European Community under the 7th Framework Program [242193/EFACTS]
Ask authors/readers for more resources
Friedreich's ataxia (FRDA) is a recessive neurodegenerative disorder commonly associated with hypertrophic cardiomyopathy. FRDA is due to expanded GAA repeats within the first intron of the gene encoding frataxin, a conserved mitochondrial protein involved in iron-sulphur cluster biosynthesis. This mutation leads to partial gene silencing and substantial reduction of the frataxin level. To overcome limitations of current cellular models of FRDA, we derived induced pluripotent stem cells (iPSCs) from two FRDA patients and successfully differentiated them into neurons and cardiomyocytes, two affected cell types in FRDA. All FRDA iPSC lines displayed expanded GAA alleles prone to high instability and decreased levels of frataxin, but no biochemical phenotype was observed. Interestingly, both FRDA iPSC-derived neurons and cardiomyocytes exhibited signs of impaired mitochondrial function, with decreased mitochondrial membrane potential and progressive mitochondrial degeneration, respectively. Our data show for the first time that FRDA iPSCs and their neuronal and cardiac derivatives represent promising models for the study of mitochondrial damage and GAA expansion instability in FRDA.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available